BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sumavel DosePro sumatriptan regulatory update

Zogenix began a named-patient program to provide access to Sumavel DosePro sumatriptan injection. The sumatriptan injection delivered via the needle-free DosePro system is marketed in the U.S. and Germany to treat...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >